lipodystrophy: a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. ("Lipo" is Greek for "fat", and "dystrophy" is Greek for "abnormal or degenerative condition".)
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
56 |
4. Check minimum number of eventsNone |
56 |
5. Include endpointsNone |
56 |
6. Filter based on genotype QC (FinnGen only) |
53 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E88
- Name in latin
- Lipodystrophia non alibi classificata
Similar endpoints
↥List of similar endpoints to
Lipodystrophy, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other metabolic disorders
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 334 | 268 | 64 |
| Only index persons | 300 | 253 | 47 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 43.45 | 43.19 | 44.22 |
| Only index persons | 43.54 | 42.71 | 48.02 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 53 | 42 | 11 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 50.79 | 49.36 | 56.23 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 56
- Matched controls
- 560
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A98, ,
ICD-O-3
+∞
72.8
53
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
62.8
48
*
E881, ,
ICD-10 Finland
Lipodystrophy, not elsewhere classified
+∞
62.8
48
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
62.8
48
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
59.3
46
*
J01DB01, ,
ATC
cefalexin; oral
+∞
54.2
43
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
48.0
39
*
GD1AA, ,
ICD-O-3
+∞
40.6
34
*
WX110, ,
ICD-O-3
+∞
40.6
34
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
39.2
33
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
39.2
33
*
SAA02, ,
ICD-O-3
+∞
39.2
33
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
37.9
32
*
M03BX02, ,
ATC
tizanidine; oral
+∞
37.9
32
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
35.1
30
*
SAA01, ,
ICD-O-3
+∞
35.1
30
*
J01DA01, ,
ATC
[U] cefalexin
+∞
35.1
30
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
33.8
29
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
33.8
29
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
33.8
29
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
32.5
28
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
32.5
28
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
31.2
27
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
31.2
27
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
29.9
26
*
R06AE07, ,
ATC
cetirizine; oral
+∞
29.9
26
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
28.6
25
*
E0000UV, ,
ATC
+∞
28.6
25
*
K021, ,
ICD-O-3
+∞
28.6
25
*
SFA20, ,
ICD-O-3
+∞
28.6
25
*
SFA10, ,
ICD-O-3
+∞
27.3
24
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
26.1
23
*
EB1AA, ,
ICD-O-3
+∞
26.1
23
*
R01AD09, ,
ATC
mometasone; nasal
+∞
26.1
23
*
SAA03, ,
ICD-O-3
+∞
24.8
22
*
EB1HA, ,
ICD-O-3
+∞
24.8
22
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
24.8
22
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
24.8
22
*
EB1SA, ,
ICD-O-3
+∞
24.8
22
*
Z871, ,
ICD-O-3
+∞
24.8
22
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
23.6
21
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
23.6
21
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
23.6
21
*
KMAK, ,
ICD-O-3
+∞
23.6
21
*
S18, ,
ICD-O-3
+∞
22.4
20
*
I10, ,
ICD-O-3
+∞
22.4
20
*
SFA30, ,
ICD-O-3
+∞
22.4
20
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
22.4
20
*
WZC00, ,
ICD-O-3
+∞
21.2
19
*
D07AC01, ,
ATC
betamethasone; topical
+∞
21.2
19
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
21.2
19
*
M02AA07, ,
ATC
piroxicam; topical
+∞
21.2
19
*
R06AX27, ,
ATC
desloratadine; oral
+∞
21.2
19
*
WX290, ,
ICD-O-3
+∞
21.2
19
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
21.2
19
*
SPAT1310, ,
ICD-O-3
+∞
21.2
19
*
SDA02, ,
ICD-O-3
+∞
20.0
18
*
LC2BE, ,
ICD-O-3
+∞
20.0
18
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
20.0
18
*
SPAT1249, ,
ICD-O-3
+∞
20.0
18
*
AA1AD, ,
ICD-O-3
+∞
20.0
18
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
20.0
18
*
WYA05, ,
ICD-O-3
+∞
18.8
17
*
Z012, ,
ICD-O-3
+∞
18.8
17
*
WX408, ,
ICD-O-3
+∞
18.8
17
*
SPAT1256, ,
ICD-O-3
+∞
18.8
17
*
K0364, ,
ICD-O-3
+∞
18.8
17
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
18.8
17
*
C10AA01, ,
ATC
simvastatin; oral
+∞
18.8
17
*
Z2221, ,
ICD-O-3
+∞
18.8
17
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
17.6
16
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
17.6
16
*
TPH04, ,
ICD-O-3
+∞
17.6
16
*
SPAT1263, ,
ICD-O-3
+∞
17.6
16
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
17.6
16
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
17.6
16
*
UJD10, ,
ICD-O-3
+∞
17.6
16
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
17.6
16
*
WW200, ,
ICD-O-3
+∞
17.6
16
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
17.6
16
*
215, ,
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
16.4
15
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
16.4
15
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
16.4
15
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
16.4
15
*
SDA03, ,
ICD-O-3
+∞
16.4
15
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
16.4
15
*
C08CA01, ,
ATC
amlodipine; oral
+∞
16.4
15
*
R4110, ,
ICD-O-3
+∞
16.4
15
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
16.4
15
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
16.4
15
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
15.3
14
*
J069, ,
ICD-O-3
+∞
15.3
14
*
-1, ,
ICD-O-3
+∞
15.3
14
*
R01AD58, ,
ATC
fluticasone, combinations; nasal
+∞
15.3
14
*
SPAT1325, ,
ICD-O-3
+∞
15.3
14
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
15.3
14
*
N05CF01, ,
ATC
zopiclone; oral
+∞
15.3
14
*
N05BA04, ,
ATC
oxazepam; oral
+∞
15.3
14
*
ZXA00, ,
ICD-O-3
+∞
15.3
14
*
C03CA01, ,
ATC
furosemide; systemic
+∞
14.1
13
*
Z3231, ,
ICD-O-3
+∞
14.1
13
*
WX402, ,
ICD-O-3
+∞
14.1
13
*
L03, ,
ICD-O-3
+∞
14.1
13
*
C09CA01, ,
ATC
losartan; oral
+∞
14.1
13
*
D07AC13, ,
ATC
mometasone; topical
+∞
14.1
13
*
SPAT1153, ,
ICD-O-3
+∞
14.1
13
*
L17, ,
ICD-O-3
+∞
14.1
13
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
14.1
13
*
C09AA05, ,
ATC
ramipril; oral
+∞
14.1
13
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
14.1
13
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
14.1
13
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
14.1
13
*
SPAT1223, ,
ICD-O-3
+∞
14.1
13
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
13.0
12
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
13.0
12
*
ZXE00, ,
ICD-O-3
+∞
13.0
12
*
J01MA06, ,
ATC
norfloxacin; oral
+∞
13.0
12
*
J02AC02, ,
ATC
itraconazole; systemic
+∞
13.0
12
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
13.0
12
*
SDA04, ,
ICD-O-3
+∞
13.0
12
*
Z760, ,
ICD-O-3
+∞
13.0
12
*
ZXD10, ,
ICD-O-3
+∞
13.0
12
*
WZB00, ,
ICD-O-3
+∞
13.0
12
*
R83, ,
ICD-O-3
+∞
13.0
12
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
13.0
12
*
SPAT1253, ,
ICD-O-3
+∞
13.0
12
*
65000, ,
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
+∞
13.0
12
*
WX700, ,
ICD-O-3
+∞
13.0
12
*
CJE20, ,
ICD-O-3
+∞
13.0
12
*
A97, ,
ICD-O-3
+∞
13.0
12
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
13.0
12
*
SPAT1250, ,
ICD-O-3
+∞
13.0
12
*
Z712, ,
ICD-O-3
+∞
13.0
12
*
M796, ,
ICD-O-3
+∞
11.9
11
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
11.9
11
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
11.9
11
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
11.9
11
*
SPAT1301, ,
ICD-O-3
+∞
11.9
11
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
11.9
11
*
ZXE10, ,
ICD-O-3
+∞
11.9
11
*
S82, ,
ICD-O-3
+∞
11.9
11
*
XF400, ,
ICD-O-3
+∞
11.9
11
*
L08, ,
ICD-O-3
+∞
11.9
11
*
D07AD01, ,
ATC
clobetasol; topical
+∞
11.9
11
*
EBA00, ,
ICD-O-3
+∞
11.9
11
*
ZXD05, ,
ICD-O-3
+∞
11.9
11
*
K0382, ,
ICD-O-3
+∞
11.9
11
*
WX404, ,
ICD-O-3
+∞
11.9
11
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
11.9
11
*
N06AB10, ,
ATC
escitalopram; oral
+∞
11.9
11
*
N05CF02, ,
ATC
zolpidem; oral
+∞
11.9
11
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
11.9
11
*
C09CA06, ,
ATC
candesartan; oral
+∞
10.8
10
*
A10BA02, ,
ATC
metformin; oral
+∞
10.8
10
*
L15, ,
ICD-O-3
+∞
10.8
10
*
T90, ,
ICD-O-3
+∞
10.8
10
*
OAB43, ,
ICD-O-3
+∞
10.8
10
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
10.8
10
*
R03BA02, ,
ATC
budesonide; inhalant
+∞
10.8
10
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
10.8
10
*
XLD00, ,
ICD-O-3
+∞
10.8
10
*
C03EA01, ,
ATC
hydrochlorothiazide and potassium-sparing agents; oral
+∞
10.8
10
*
M545, ,
ICD-O-3
+∞
10.8
10
*
R103, ,
ICD-10 Finland
Pain localized to other parts of lower abdomen
+∞
10.8
10
*
N06AB04, ,
ATC
citalopram; systemic
+∞
10.8
10
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
10.8
10
*
WX320, ,
ICD-O-3
+∞
10.8
10
*
H251, ,
ICD-10 Finland
Senile nuclear cataract
+∞
10.8
10
*
E000001, ,
ATC
+∞
10.8
10
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
10.8
10
*
QDJ00, ,
ICD-O-3
+∞
10.8
10
*
R06AX13, ,
ATC
loratadine; oral
+∞
10.8
10
*
SCA01, ,
ICD-O-3
+∞
9.6
9
*
R03DC03, ,
ATC
montelukast; oral
+∞
9.6
9
*
UJF32, ,
ICD-O-3
+∞
9.6
9
*
K0365, ,
ICD-O-3
+∞
9.6
9
*
FM1AE, ,
ICD-O-3
+∞
9.6
9
*
D01AE16, ,
ATC
amorolfine; topical
+∞
9.6
9
*
WX704, ,
ICD-O-3
+∞
9.6
9
*
R06AX22, ,
ATC
ebastine; oral
+∞
9.6
9
*
Z3226, ,
ICD-O-3
+∞
9.6
9
*
D82, ,
ICD-O-3
+∞
9.6
9
*
SPAT1262, ,
ICD-O-3
+∞
9.6
9
*
SFC01, ,
ICD-O-3
+∞
9.6
9
*
FN1AC, ,
ICD-O-3
+∞
9.6
9
*
R74, ,
ICD-O-3
+∞
9.6
9
*
EBA05, ,
ICD-O-3
+∞
9.6
9
*
SDE02, ,
ICD-O-3
+∞
9.6
9
*
D19, ,
ICD-O-3
+∞
9.6
9
*
S01GX01, ,
ATC
cromoglicic acid; ophthalmic
+∞
9.6
9
*
R05, ,
ICD-O-3
+∞
9.6
9
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
9.6
9
*
A04, ,
ICD-O-3
+∞
9.6
9
*
R21, ,
ICD-O-3
+∞
9.6
9
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
9.6
9
*
QBJ00, ,
ICD-O-3
+∞
9.6
9
*
X58, ,
ICD-10 Finland
Exposure to other specified factors
+∞
9.6
9
*
D07XC01, ,
ATC
betamethasone; topical
+∞
9.6
9
*
TQW40, ,
ICD-O-3
+∞
8.5
8
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
8.5
8
*
C07AA05, ,
ATC
propranolol; systemic
+∞
8.5
8
*
D07CA01, ,
ATC
hydrocortisone and antibiotics; topical
+∞
8.5
8
*
K045, ,
ICD-O-3
+∞
8.5
8
*
UKC02, ,
ICD-O-3
+∞
8.5
8
*
SFA00, ,
ICD-O-3
+∞
8.5
8
*
SFA40, ,
ICD-O-3
+∞
8.5
8
*
L28, ,
ICD-O-3
+∞
8.5
8
*
N06AX21, ,
ATC
duloxetine; oral
+∞
8.5
8
*
R42, ,
ICD-O-3
+∞
8.5
8
*
R5110, ,
ICD-O-3
+∞
8.5
8
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
8.5
8
*
M01AG02, ,
ATC
tolfenamic acid; oral, rectal
+∞
8.5
8
*
G03FA01, ,
ATC
norethisterone and estrogen; systemic
+∞
8.5
8
*
M01AX05, ,
ATC
glucosamine; oral
+∞
8.5
8
*
VALMI, ,
ICD-O-3
+∞
8.5
8
*
M255, ,
ICD-O-3
+∞
8.5
8
*
R01BA51, ,
ATC
phenylpropanolamine, combinations; oral
+∞
8.5
8
*
GD1UA, ,
ICD-O-3
+∞
8.5
8
*
G03FB05, ,
ATC
norethisterone and estrogen; systemic
+∞
8.5
8
*
D11, ,
ICD-O-3
+∞
8.5
8
*
N951, ,
ICD-O-3
+∞
8.5
8
*
SPAT1260, ,
ICD-O-3
+∞
8.5
8
*
A10AE04, ,
ATC
insulin glargine; parenteral
+∞
8.5
8
*
N03AX16, ,
ATC
[U] pregabalin
+∞
8.5
8
*
E119, ,
ICD-O-3
+∞
8.5
8
*
ZXA05, ,
ICD-O-3
+∞
8.5
8
*
D01BA02, ,
ATC
terbinafine; oral
+∞
8.5
8
*
G02BA03, ,
ATC
plastic IUD with progestogen
+∞
8.5
8
*
2726A, ,
ICD-9 Finland
Disorders of lipoid metabolism, Lipodystrophy
+∞
8.5
8
*
Z718, ,
ICD-O-3
+∞
8.5
8
*
WX002, ,
ICD-O-3
+∞
8.5
8
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
8.5
8
*
G01AA10, ,
ATC
clindamycin; vaginal
+∞
7.4
7
*
ZXA10, ,
ICD-O-3
+∞
7.4
7
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
7.4
7
*
OAA65, ,
ICD-O-3
+∞
7.4
7
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
7.4
7
*
M02AA10, ,
ATC
ketoprofen; topical
+∞
7.4
7
*
U02, ,
ICD-O-3
+∞
7.4
7
*
LC2AE, ,
ICD-O-3
+∞
7.4
7
*
LCA13, ,
ICD-O-3
+∞
7.4
7
*
D02AE01, ,
ATC
carbamide; topical
+∞
7.4
7
*
D06, ,
ICD-O-3
+∞
7.4
7
*
E7801, ,
ICD-10 Finland
Pure hypercholesterolaemia
+∞
7.4
7
*
K449, ,
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
+∞
7.4
7
*
R104, ,
ICD-O-3
+∞
7.4
7
*
OAB48, ,
ICD-O-3
+∞
7.4
7
*
S21, ,
ICD-O-3
+∞
7.4
7
*
A10AC01, ,
ATC
insulin (human); parenteral
+∞
7.4
7
*
SPAT1097, ,
ICD-O-3
+∞
7.4
7
*
WZA90, ,
ICD-O-3
+∞
7.4
7
*
U71, ,
ICD-O-3
+∞
7.4
7
*
TQX10, ,
ICD-O-3
+∞
7.4
7
*
N17, ,
ICD-O-3
+∞
7.4
7
*
R31, ,
ICD-10 Finland
Unspecified haematuria
+∞
7.4
7
*
Z024, ,
ICD-O-3
+∞
7.4
7
*
A10AB05, ,
ATC
insulin aspart; parenteral
+∞
7.4
7
*
M03BC01, ,
ATC
orphenadrine (citrate); systemic
+∞
7.4
7
*
M255, ,
ICD-10 Finland
Pain in joint
+∞
7.4
7
*
R55, ,
ICD-10 Finland
Syncope and collapse
+∞
7.4
7
*
Z961, ,
ICD-10 Finland
Presence of intraocular lens
+∞
7.4
7
*
R03AK06, ,
ATC
salmeterol and fluticasone; inhalant
+∞
7.4
7
*
G03DB01, ,
ATC
dydrogesterone; oral
+∞
7.4
7
*
SDA01, ,
ICD-O-3
+∞
7.4
7
*
N01, ,
ICD-O-3
+∞
7.4
7
*
C03DA01, ,
ATC
spironolactone; oral
+∞
7.4
7
*
S29, ,
ICD-O-3
+∞
7.4
7
*
N03AX12, ,
ATC
[U] gabapentin; oral
+∞
7.4
7
*
M01AH02, ,
ATC
rofecoxib; oral
+∞
7.4
7
*
R06AE09, ,
ATC
levocetirizine; oral
+∞
7.4
7
*
FM1EE, ,
ICD-O-3
+∞
7.4
7
*
SPAT1324, ,
ICD-O-3
+∞
7.4
7
*
NA3BG, ,
ICD-O-3
+∞
7.4
7
*
HA1AE, ,
ICD-O-3
+∞
7.4
7
*
N06AB05, ,
ATC
paroxetine; oral
+∞
7.4
7
*
QAE10, ,
ICD-O-3
+∞
7.4
7
*
SPAT1312, ,
ICD-O-3
+∞
7.4
7
*
D07AA02, ,
ATC
hydrocortisone; topical
+∞
6.4
6
*
R876, ,
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
+∞
6.4
6
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
6.4
6
*
R01AD01, ,
ATC
beclometasone; nasal
+∞
6.4
6
*
A03FA02, ,
ATC
cisapride; oral, rectal
+∞
6.4
6
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
6.4
6
*
P03, ,
ICD-O-3
+∞
6.4
6
*
SPAT1283, ,
ICD-O-3
+∞
6.4
6
*
XF402, ,
ICD-O-3
+∞
6.4
6
*
J010, ,
ICD-O-3
+∞
6.4
6
*
F3210, ,
ICD-10 Finland
Moderate depressive episode without somatic syndrome
+∞
6.4
6
*
C09AA02, ,
ATC
enalapril; systemic
+∞
6.4
6
*
R05, ,
ICD-10 Finland
Cough
+∞
6.4
6
*
G560, ,
ICD-10 Finland
Carpal tunnel syndrome
+∞
6.4
6
*
R13, ,
ICD-10 Finland
Dysphagia
+∞
6.4
6
*
L12, ,
ICD-O-3
+∞
6.4
6
*
SDE03, ,
ICD-O-3
+∞
6.4
6
*
F29, ,
ICD-O-3
+∞
6.4
6
*
R060, ,
ICD-O-3
+∞
6.4
6
*
M190, ,
ICD-10 Finland
Primary arthrosis of other joints
+∞
6.4
6
*
K020, ,
ICD-O-3
+∞
6.4
6
*
N05AH04, ,
ATC
quetiapine; oral
+∞
6.4
6
*
HA1AA, ,
ICD-O-3
+∞
6.4
6
*
C01DA02, ,
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
+∞
6.4
6
*
N05BA12, ,
ATC
alprazolam; oral
+∞
6.4
6
*
N06AX26, ,
ATC
vortioxetine; oral
+∞
6.4
6
*
M01AH01, ,
ATC
celecoxib; oral
+∞
6.4
6
*
M751, ,
ICD-O-3
+∞
6.4
6
*
J459, ,
ICD-10 Finland
Asthma, unspecified
+∞
6.4
6
*
A02BA02, ,
ATC
ranitidine; systemic
+∞
6.4
6
*
R03BA01, ,
ATC
beclometasone; inhalant
+∞
6.4
6
*
G01AF05, ,
ATC
econazole; vaginal
+∞
6.4
6
*
L13, ,
ICD-O-3
+∞
6.4
6
*
H02AB07, ,
ATC
prednisone; oral
+∞
6.4
6
*
H400, ,
ICD-10 Finland
Glaucoma suspect
+∞
6.4
6
*
K0510, ,
ICD-O-3
+∞
6.4
6
*
SGC00, ,
ICD-O-3
+∞
6.4
6
*
N06AB03, ,
ATC
fluoxetine; oral
+∞
6.4
6
*
A03, ,
ICD-O-3
+∞
6.4
6
*
TPH07, ,
ICD-O-3
+∞
6.4
6
*
S0251, ,
ICD-O-3
+∞
6.4
6
*
AN1, ,
ICD-O-3
+∞
6.4
6
*
NG1AA, ,
ICD-O-3
+∞
6.4
6
*
G03AC03, ,
ATC
levonorgestrel; oral, implant
+∞
6.4
6
*
A28, ,
ICD-O-3
+∞
6.4
6
*
M01AC01, ,
ATC
piroxicam; systemic, rectal
+∞
6.4
6
*
N06AX16, ,
ATC
venlafaxine; oral
+∞
6.4
6
*
S525, ,
ICD-10 Finland
Fracture of lower end of radius
+∞
6.4
6
*
PA6DE, ,
ICD-O-3
+∞
6.4
6
*
SPAT1028, ,
ICD-O-3
+∞
6.4
6
*
R42, ,
ICD-10 Finland
Dizziness and giddiness
+∞
6.4
6
*
EBA10, ,
ICD-O-3
+∞
6.4
6
*
K85, ,
ICD-O-3
+∞
6.4
6
*
U072, ,
ICD-O-3
+∞
6.4
6
*
R4120, ,
ICD-O-3
+∞
6.4
6
*
A06AD11, ,
ATC
lactulose; oral
+∞
6.4
6
*
N02AE01, ,
ATC
buprenorphine; parenteral, sublingual, transdermal
+∞
6.4
6
*
F329, ,
ICD-10 Finland
Depressive episode, unspecified
+∞
6.4
6
*
L82, ,
ICD-O-3
+∞
6.4
6
*
JN1AE, ,
ICD-O-3
+∞
6.4
6
*
A10AB04, ,
ATC
insulin lispro; parenteral
+∞
6.4
6
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
6.4
6
*
R03BA08, ,
ATC
ciclesonide; inhalant
+∞
6.4
6
*
I639, ,
ICD-10 Finland
Cerebral infarction, unspecified
+∞
6.4
6
*
I251, ,
ICD-10 Finland
Atherosclerotic heart disease
+∞
6.4
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
8
20
4.48
2.68
4.0
2.0
5.35
5.28
kpa
—
8
20
5
7
7.69
2.60
1.4
1.0
—
—
—
0
0
8
21
4.26
2.57
4.6
1.3
—
—
—
0
0
32
208
2.26
2.27
7.2
4.4
1.22
1.23
mmol/l
0.10
27
176
5
10
5.36
2.11
3.0
1.9
151.80
146.20
%
—
5
10
28
184
2.04
1.82
7.4
4.1
1.23
1.23
mmol/l
0.13
23
165
8
33
2.66
1.61
11.3
4.9
13.65
11.85
kpa
—
8
33
8
33
2.66
1.61
11.3
4.9
4.90
4.97
kpa
—
8
33
0
45
0.00
1.58
0.0
3.7
—
1.23
—
0
37
25
165
1.93
1.55
2.5
1.9
105.65
97.25
pmol/l
0.46
15
91
5
18
2.94
1.31
1.8
1.6
—
—
—
0
0
28
201
1.79
1.28
4.1
2.1
75.95
76.39
nmol/l
0.03
22
174
48
422
1.96
1.01
8.3
4.9
40.45
38.54
mmol/mol
0.61
43
382
6
28
2.28
0.95
13.7
5.3
119.00
121.46
g/l
—
6
28
27
207
1.59
0.88
2.9
2.4
—
—
—
0
0
16
111
1.62
0.77
3.9
2.3
265.09
915.09
ng/l
1.77
11
90
7
41
1.81
0.73
2.9
1.5
—
—
—
0
0
7
41
1.81
0.73
2.9
1.5
—
—
—
0
0
7
41
1.81
0.73
18.3
4.5
107.29
104.49
mmol/l
—
7
41
5
27
1.93
0.70
3.2
1.6
—
—
—
0
0
13
88
1.62
0.68
2.1
1.7
0.54
0.91
mg/l
—
8
67
36
307
1.48
0.65
2.9
3.3
—
—
—
0
0
20
152
1.49
0.64
6.8
2.9
—
—
—
0
0
51
474
1.85
0.62
17.3
10.5
20.64
20.03
mg/l
0.05
40
339
0
21
0.00
0.61
0.0
1.6
—
1107.10
—
0
10
10
65
1.66
0.60
2.4
1.5
—
—
—
0
0
50
464
1.72
0.58
5.8
4.6
1.86
1.87
mu/l
0.03
44
418
9
60
1.59
0.58
14.2
2.6
0.81
0.83
mmol/l
—
9
52
21
166
1.42
0.54
2.6
2.8
14.16
26.93
ng/l
1.80
14
108
7
45
1.63
0.51
2.0
1.7
—
—
—
0
0
7
47
1.56
0.50
3.3
2.4
7.34
10.31
umol/l
—
7
40
7
47
1.56
0.50
1.7
2.9
26.57
29.78
u/l
—
7
36
15
191
0.71
0.47
6.3
3.2
—
—
—
0
0
0
15
0.00
0.42
0.0
1.4
—
—
—
0
0
15
117
1.39
0.41
1.7
1.3
—
—
—
0
0
13
99
1.41
0.40
1.9
1.9
—
—
—
0
0
16
128
1.35
0.37
2.9
1.8
118.94
119.49
u/l
0.01
16
118
16
136
1.25
0.23
6.2
2.2
54.19
53.24
u/l
0.07
16
123
48
456
1.37
0.23
17.2
10.1
80.82
83.23
ml/min/173m2
0.32
36
370
45
427
1.27
0.22
22.6
12.8
15.78
14.86
%
0.33
45
419
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
3.2
—
38.27
—
0
10
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
7
60
1.19
0.18
2.7
7.2
—
—
—
0
0
49
475
1.25
0.16
6.9
4.6
2.55
2.83
mmol/l
1.62
44
428
48
464
1.24
0.15
5.4
4.4
6.06
5.73
mmol/l
0.71
43
420
11
95
1.20
0.13
1.5
1.7
—
—
—
0
0
5
48
1.05
0.09
2.0
1.4
1.36
1.40
%
—
5
43
8
75
1.08
0.08
6.4
4.7
1.79
1.75
ug/l
—
8
64
38
389
0.93
0.03
4.8
3.9
14.95
14.69
pmol/l
0.26
33
346
11
108
1.02
0.00
6.9
2.5
34279.18
10938.18
umol/l
0.29
11
92
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
56
0.88
-0.00
4.4
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.6
—
—
—
0
0
8
84
0.94
-0.00
1.6
2.2
2.43
2.45
mmol/l
—
8
74
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
51
506
1.09
-0.00
22.3
12.3
74.53
71.73
umol/l
0.45
51
506
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_LIPODYST and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have E4_LIPODYST.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: E4_LIPODYST – Lipodystrophy, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data